Beyond its role in cell-cycle dysregulation, PLK1 significantly promotes cancer progression via metabolic reprogramming, including enhancing the flux of the pentose phosphate pathway and directing glucose to pathways involved in the synthesis of macromolecules [16]. This evidence concerns the gene PLK1 and cancer.